Financhill
Back

Penumbra 10K Form

Sell
50

PEN
Penumbra

Last Price:
195.07
Seasonality Move:
1.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive PEN News And Ratings

See the #1 stock for the next 7 days that we like better than PEN

PEN Financial Statistics

Sales & Book Value

Annual Sales: $1.06B
Cash Flow: $18.08M
Price / Cash Flow: 68.96
Annual Sales: $29.90
Price / Book: 6.52

Profitability

EPS (TTM): 0.34000
Net Income (TTM): $14.23M
Gross Margin: $682.64M
Return on Equity: 1.25%
Return on Assets: 0.94%

Penumbra Earnings Forecast

Key Penumbra Financial Ratios

  • The Gross Profit Margin over the past 12 years for PEN is 64.49%.
  • The Selling, General & Administrative Expenses for PEN have been equal to 47.85% of Gross Profit Margin.
  • The Research & Development expenses have been 7.98% of Revenue.
  • The Interest Expense is 1.91% of Operating Income.
  • The Net Earning history of PEN is 8.59% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Penumbra Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PEN
CUSIP: 70975L
Website: penumbrainc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.25
Quick Ratio: 3.58

Price-to-Earnings

Trailing P/E Ratio: 83.97
Forward P/E Ratio: 54.79

PEN Technical Analysis vs Fundamental Analysis

Sell
50
Penumbra (PEN) is a Sell

Is Penumbra a Buy or a Sell?

  • Penumbra stock is rated a Sell
    The current Penumbra [PEN] share price is $194.81. The Score for PEN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.